Categories: Company News

Fluke Biomedical Acquires Unfors RaySafe


Sweden February 12, 2014:-
Fluke Biomedical, the world’s leading manufacturer of biomedical test instruments, announced today the acquisition of Unfors RaySafe. 
 
With this acquisition Fluke Biomedical adds industry leading quality assurance devices for diagnostic x-ray from Unfors RaySafe. With an enhanced portfolio especially in the fields of diagnostic x-ray, real-time dose monitoring systems for medical personnel and patient dose tracking software solutions, the Unfors RaySafe product line will broaden the Fluke Biomedical customer base and answer market demands with innovative and state-of-the-art solutions. Fluke Biomedical‘s goal is to provide healthcare providers, institutions and medical device manufacturers with a complete portfolio of test equipment.
 
Both companies see the user friendliness of their products, combined with advanced technology and maximum measurement accuracy as their major assets. “The fact that our companies share a similar culture is an ideal basis for continuing our excellent relationships with our employees, customers and partners,” says Magnus Kristoferson, CEO of Unfors RaySafe. “We have experience in highly specialized markets all over the world, we know our business and we can now maximize our competencies. In the past, Unfors RaySafe has attracted the attention of the market not just for the functionality and measurement accuracy of its products, but also for the attractive design and intuitive user interface.”
 
Fluke Biomedical leads the world in the manufacture of biomedical test and simulation products, including electrical safety testers, patient simulators, performance analyzers, and fully-integrated and automated performance testing and documentation systems. Fluke Biomedical General Manager, Eric Conley says, “The acquisition of Unfors RaySafe brings to Fluke Biomedical a strong team that has delivered leading innovation to the radiation test and safety markets. The combination of Unfors RaySafe and Fluke Biomedical accelerates our ability to provide a broad portfolio of world class test equipment to our customers.” With worldwide sales and distribution channels, Fluke Biomedical anticipates growth through innovative design and creative solutions for their customers. Fresh perspectives and product enhancements, coupled with the commitment to customer satisfaction, remain the hallmark of the organization. –

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

14 hours ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

2 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

2 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago